A fixed, low dose of anti-CD20 antibody (Rituximab) is an effective treatment for patients with chronic immune thrombocytopenia

被引:0
|
作者
El-Najjar, I [1 ]
Rule, SAJ [1 ]
Nokes, TJC [1 ]
机构
[1] Derriford Hosp, Dept Haematol, Plymouth PL6 8DH, Devon, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:79 / 80
页数:2
相关论文
共 50 条
  • [31] Results of treatment with rituximab (Anti-CD20) in three patients with autoimmune hemolytic anemia and/or immune thrombocytopenia and a concise review of reported cases
    Ahrens, N
    Heymann, G
    Meyer, O
    Kiesewetter, H
    Salama, A
    INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 2002, 29 (05): : 277 - 281
  • [32] Chimeric monoclonal anti-CD20 antibody (rituximab) - an effective treatment for a patient with relapsing hairy cell leukaemia
    Hagberg, H
    MEDICAL ONCOLOGY, 1999, 16 (03) : 221 - 222
  • [33] Chimeric monoclonal anti-CD20 antibody (rituximab)—an effective treatment for a patient with relapsing hairy cell leukaemia
    H Hagberg
    Medical Oncology, 1999, 16 : 221 - 222
  • [34] Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab)
    Arzoo, K
    Sadeghi, S
    Liebman, HA
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) : 922 - 924
  • [35] Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus
    ten Cate, R
    Smiers, FJ
    Bredius, RGM
    Lankester, AC
    van Suijlekom-Smit, LWA
    Huizinga, TW
    Egeler, RM
    RHEUMATOLOGY, 2004, 43 (02) : 244 - 245
  • [36] Anti-CD20 (rituximab) treatment for atopic eczema
    Sediva, Anna
    Kayserova, Jana
    Vernerova, Eva
    Polouckova, Andrea
    Capkova, Stepanka
    Spisek, Radek
    Bartunkova, Jirina
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (06) : 1515 - 1516
  • [37] Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis
    Bhatia, A
    Ell, PJ
    Edwards, JCW
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (07) : 1099 - 1100
  • [38] Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 antibody Rituximab.
    Giagounidis, AAN
    Anhuf, J
    Schneider, P
    Germing, U
    Soehngen, D
    Quabeck, K
    Aul, C
    BLOOD, 2001, 98 (11) : 523A - 523A
  • [39] Idiopathic membranous nephropathy (IMN) treatment with anti-CD20 monoclonal antibody Rituximab
    Lionaki, Sofia
    Sfikakis, Petros
    Theodoropoulou, Eleni
    Skalioti, Chrisanthi
    Iniotaki, Aliki
    Nakopoulou, Lydia
    Boletis, Ioannis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 334 - 335
  • [40] Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia
    Hagberg, H
    Lundholm, L
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (03) : 609 - 611